It’s Official: Pershing Square Capital’s Bill Ackman joins JC Penney’s Board

Leading shareholder activist investor Bill Ackman, who is the CEO of Pershing Square Capital Management, officially joined the board of retailer J.C. Penney Company, Inc. (NYSE: JCP) this week. Mr. Ackman joins the board with Steven Roth, who Pershing Square Capital had also nominated to the board as part of its successful activist campaign against J.C. Penney. Mr. Roth is also currently chairman of the board of Vornado Realty Trust.

Read Full Article

Hedge Funds post Mixed Results; Third Point, Tremblant Partners & Pershing Square among Winners

Thought the below article on hedge fund performance in February was interesting.
http://www.hedgetracker.com/article/Hedge-Funds-post-Mixed-Results-Third-Point-Tremblant-Partners-Pershing-Square-among-Winners

It also highlight the performance of industry stalwarts:
Daniel Loeb's Third Point http://www.hedgetracker.com/thirdpoint.php
Bret Barakett's Tremblant Capital http://www.hedgetracker.com/fund/Tremblant-Capital
Bill Ackman's Pershing Square http://www.hedgetracker.com/pershing.php

What is an activist investor?

Micahel Levin recently launched The Activist Investor, an advisory firm for investment managers that want to employ shareholder activist strategies with their investment companies. Beyond its services, the firm's website also includes great resources for those interested in shareholder activisms. Check it out at: http://www.theactivistinvestor.com/

Carl Icahn eyes Biotech leader Genzyme Corp

Here is an article on Carl Icahm, one my favorite shareholder activist. In in his latest activist battle, Icahn is taking on troubled biotech company Genzyme Corp.
http://www.hedgetracker.com/article/Carl-Icahn-eyes-Biotech-leader-Genzyme-Corp
More details on Mr. Ichan and his hedge fund firm can be out found here:
http://www.hedgetracker.com/icahn.php